跳至主要内容
MedPath Trial logoMedPath TrialMedPath Trial Home
临床试验/CTRI/2018/03/012366
CTRI/2018/03/012366招募中不适用

Study of usage and outcomes of Polymyxin B for Systemic Bacterial Infections in Indian patients: A Prospective Registry Study

Wockhardt Limited1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2017年11月5日最近更新:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
100
试验地点
1
主要终点
Pattern of usage of Polymyxin B in various healthcare setups
研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

This present study aims to monitor and record the patterns of usage, clinical practices and the determinants & outcomes (efficacy and safety) of such practices in regards to administration of Polymyxin B in large Indian population in real life scenarios for management of systemic bacterial infections as per routine clinical practice.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 99.00 Year(s)（—）
性别
All

入选标准

  • •An Adult (> 18 years) Indian patient of either gender who is reported to have received at least 1 dose of Polymyxin B for management of systemic bacterial infection
  • •Patient provides consent for recording of patient related data from medical records into the registry.

排除标准

  • •Adult less than 18 years of age
  • •Patients not received at least 1 dose of Polymyxin B for management of systemic bacterial infection.

结局指标

主要结局

Pattern of usage of Polymyxin B in various healthcare setups

时间窗: 12months

2. Outcomes associated with therapy with Polymyxin B

时间窗: 12months

次要结局

  • Demographic and disease distribution of usage of Polymyxin B
  • Incidence of side effects and / or development of abnormal laboratory parameters(12 months)

研究者

申办方类型
Private hospital/clinic

研究点 (1)

Loading locations...

相似试验

招募中
不适用
Study of usage and outcomes of Polymyxin B in serious Bacterial Infections in Indian patients
CTRI/2018/03/012366Wockhardt Limited
进行中（未招募）
不适用
Study of usage and outcomes of Polymyxin B in serious bacterial infectio
CTRI/2018/02/012183Wockhardt Limited
进行中（未招募）
不适用
Study of usage and outcomes of Polymyxin B in serious bacterial infectionIndian patients who are administered Polymyxin B for management of systemic bacterial infection as per routine clinical practice
CTRI/2018/02/012183Wockhardt Limited50
已完成
不适用
Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Septic ShockEndotoxemiaSeptic Shock
NCT01046669Spectral Diagnostics (US) Inc.450
已完成
不适用
Optimizing Clinical Use of Polymyxin BRespiratory Tract Infection (Including Tracheobronchitis)Blood Stream InfectionUrinary Tract InfectionsSepsisPneumonia
NCT02682355Rutgers, The State University of New Jersey155